These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
421 related articles for article (PubMed ID: 29438542)
1. Discovery and development of new antibacterial drugs: learning from experience? Jackson N; Czaplewski L; Piddock LJV J Antimicrob Chemother; 2018 Jun; 73(6):1452-1459. PubMed ID: 29438542 [TBL] [Abstract][Full Text] [Related]
2. Something old, something new: revisiting natural products in antibiotic drug discovery. Wright GD Can J Microbiol; 2014 Mar; 60(3):147-54. PubMed ID: 24588388 [TBL] [Abstract][Full Text] [Related]
3. The future of natural products as a source of new antibiotics. Luzhetskyy A; Pelzer S; Bechthold A Curr Opin Investig Drugs; 2007 Aug; 8(8):608-13. PubMed ID: 17668363 [TBL] [Abstract][Full Text] [Related]
4. The antibiotic pipeline: reviving research and development and speeding drugs to market. Luepke KH; Mohr JF Expert Rev Anti Infect Ther; 2017 May; 15(5):425-433. PubMed ID: 28306360 [TBL] [Abstract][Full Text] [Related]
5. Time for a change: addressing R&D and commercialization challenges for antibacterials. Payne DJ; Miller LF; Findlay D; Anderson J; Marks L Philos Trans R Soc Lond B Biol Sci; 2015 Jun; 370(1670):20140086. PubMed ID: 25918443 [TBL] [Abstract][Full Text] [Related]
6. Challenges of antibacterial discovery revisited. Gwynn MN; Portnoy A; Rittenhouse SF; Payne DJ Ann N Y Acad Sci; 2010 Dec; 1213():5-19. PubMed ID: 21058956 [TBL] [Abstract][Full Text] [Related]
8. Antibiotic research and development: business as usual? Harbarth S; Theuretzbacher U; Hackett J; J Antimicrob Chemother; 2015; 70(6):1604-7. PubMed ID: 25673635 [TBL] [Abstract][Full Text] [Related]
9. Discovery research: the scientific challenge of finding new antibiotics. Livermore DM; J Antimicrob Chemother; 2011 Sep; 66(9):1941-4. PubMed ID: 21700626 [TBL] [Abstract][Full Text] [Related]
10. The antibiotic resistance crisis, with a focus on the United States. Martens E; Demain AL J Antibiot (Tokyo); 2017 May; 70(5):520-526. PubMed ID: 28246379 [TBL] [Abstract][Full Text] [Related]
11. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
12. Antibacterial drug discovery: is it all downhill from here? Projan SJ; Shlaes DM Clin Microbiol Infect; 2004 Nov; 10 Suppl 4():18-22. PubMed ID: 15522036 [TBL] [Abstract][Full Text] [Related]
15. Why is big Pharma getting out of antibacterial drug discovery? Projan SJ Curr Opin Microbiol; 2003 Oct; 6(5):427-30. PubMed ID: 14572532 [TBL] [Abstract][Full Text] [Related]
16. Antibacterial drug discovery: is small pharma the solution? Boggs AF; Miller GH Clin Microbiol Infect; 2004 Nov; 10 Suppl 4():32-6. PubMed ID: 15522038 [TBL] [Abstract][Full Text] [Related]
17. New antibiotics from Nature's chemical inventory. Wencewicz TA Bioorg Med Chem; 2016 Dec; 24(24):6227-6252. PubMed ID: 27658795 [TBL] [Abstract][Full Text] [Related]
20. Antibacterial research and development in the 21(st) Century--an industry perspective of the challenges. Thomson CJ; Power E; Ruebsamen-Waigmann H; Labischinski H Curr Opin Microbiol; 2004 Oct; 7(5):445-50. PubMed ID: 15451498 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]